Ferring AB

Type: Company
Name: Ferring AB
First reported 3 hours ago - Updated 3 hours ago - 1 reports

Lorna Berwick

In the Brighton County Court No 309 of 2014 In Bankruptcy Residential address: 9 Onslow Drive, Ferring, Worthing, BN12 5RP. Date of Birth: 17 June 1948. Occupation: Unknown. Notice is he… ... [Published Gazette - 3 hours ago]
First reported 11 hours ago - Updated 11 hours ago - 1 reports

Historic pond gets a new lease of life

CONSERVATIONISTS began restoring a historic pond last Saturday in a bid to make it a thriving habitat for wildlife.Members of the Ferring Conservation Group were joined by Ferring Parish Councillors at the Warren Pond in South Ferring, to begin the long-term ... [Published West Sussex Today - 11 hours ago]
Entities: Ferring AB, Habitat
First reported Oct 20 2014 - Updated Oct 20 2014 - 1 reports

BRIEF-Cosmo Pharmaceuticals says Ferring's CORTIMENT MMX receives European approval

Oct 20 (Reuters) - Cosmo Pharmaceuticals SpA :* Says Ferring's CORTIMENT MMX, a new treatment forulcerative colitis, receives European approval* Says CORTIMENT MMX has received marketing approval from 27European Union member states following EU mutual ... [Published Reuters - Oct 20 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 1 reports

TxCell to present on T cellular therapy for autoimmune diseases at National Bio-Therapy Conference 2014

TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces  that Dr Miguel Forte, sr. VP clinical ... [Published PharmaBiz - Oct 20 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 1 reports

September and October SMC decisions

The Scottish Medicines Consortium (SMC) has accepted the following medicines for restricted use in NHS Scotland; alogliptin (Vipidia; Takeda), alogliptin plus metformin combination tablet (Vipdomet; Takeda), brentuximab vedotin (Adcetris; Takeda), capsaicin ... [Published Pharmaceutical Journal - Oct 16 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 2 reports

TxCell to provide overview of T cellular therapy at 7th National Bio-Therapy Conference

TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that ... [Published News-Medical.Net - Oct 16 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 1 reports

Key Cosmo shareholders announce that they support the change of seat and will not tender shares

Lainate, Italy - October 16, 2014 - Cosmo Pharmaceuticals S.p.A. (SIX: COPN) announced that Cosmo Holding & Management Group, dievini Hopp biotech GmbH & Co KG and the Heinrich Herz AG/Logistable Group, which together control 65.8% of the issued shares, ... [Published 4 Traders - Oct 16 2014]
First reported Oct 15 2014 - Updated Oct 15 2014 - 1 reports

Is a Statutory Patent Disclaimer Sufficient Enough to Trigger Hatch-Waxman Declaratory Judgment Jurisdiction? Two District Courts Reach Opposite Conclusions

By Kurt R. Karst –For several months now we have been monitoring an appeal to the U.S. Court of Appeals for the Federal Circuit concerning a patent – U.S. Patent No. 6,878,703 (“the ‘703 patent”) – listed in the Orange Book for Daiichi Sankyo Inc.’s (“Daiichi”) ... [Published FDA Law Blog - Oct 15 2014]
First reported Oct 15 2014 - Updated Oct 15 2014 - 1 reports

FDA grants a combo-med exclusivity wish. Why is that a problem?

What's two extra years of exclusivity worth? Enough to spark a legal fight. The FDA posted new guidance on its website Friday, awarding certain combo meds 5 years of exclusivity compared with the previous three. Drugmakers had lobbied for the change, ... [Published FiercePharma - Oct 15 2014]
First reported Oct 15 2014 - Updated Oct 15 2014 - 1 reports

Ferring B.V. v. Watson Labs., Inc.—Florida (I)

Case Name: Ferring B.V. v. Watson Labs., Inc.—Florida I , No. 2014-1377 (Fed. Cir. Aug. 22, 2014) (Circuit Judges Lourie, Dyk, and Reyna presiding; Opinion by Dyk, J.) (Appeal from D. Nev., Jones, J.)Drug Product and Patent(s)-in-Suit: Lysteda® (tranexamic ... [Published JD Supra - Oct 15 2014]
First reported Oct 09 2014 - Updated Oct 09 2014 - 2 reports

Standard Heightened for Injunction in Trademark Cases

"Reprinted with permission from the October 7, 2014 issue of The Legal Intelligencer. (c) 2014 ALM Media Properties, LLC. Further duplication without permission is prohibited. All rights reserved."The U.S. Court of Appeals for the Third Circuit has reversed ... [Published JD Supra - Oct 09 2014]
First reported Sep 23 2014 - Updated Sep 24 2014 - 7 reports

Customer helps stop Walgreens robbery — with body slam | Video

A Florida woman was mere steps from a getaway when she tried to rob a Walgreens in DeLand.But a customer named Tim Tyger put a stop to it — Tyger grabbed Shanna Ferring, 37, slammed her to the ground and held her until police arrived, .Ferring tried to ... [Published The Palm Beach Post - Sep 24 2014]

Quotes

The presentation will be entitled "T Cellular Therapy for Autoimmune Diseases: from Product Development to Market Access" and is scheduled for Saturday, October 25, 2014 at 10.40 a.m. local time
"Reprinted with permission from the October 7, 2014 issue of The Legal Intelligencer. (c) 2014 ALM Media Properties, LLC. Further duplication without permission is prohibited. All rights reserved."
"Since our launch of orange-flavour Prepopik in 2012, Ferring has been committed to colon cancer screening and the importance of early detection through colonoscopy. Thorough colon cleansing is essential to a successful colonoscopy, and now with the approval of new cranberry flavour Prepopik, patients have two flavour choices, with the least amount of medicine to drink. Ferring is committed to providing effective pharmaceutical options for patients who are preparing for their colonoscopy procedure" says Andrew Zanga, head of the US Gastroenterology business unit at Ferring Pharmaceuticals Inc
...selected some of Yamaha’s outstanding pianos for performers to play and audiences to enjoy in this new, world-class jazz center,” Bezursik said. "The C7 has been the piano of choice for jazz musicians for decades, so it's an excellent instrument for the Bistro and the artists who perform there."

More Content

All (121) | News (105) | Reports (0) | Blogs (13) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Lorna Berwick [Published Gazette - 3 hours ago]
Historic pond gets a new lease of life [Published West Sussex Today - 11 hours ago]
Fertility Preservation Options for Cancer Patie... [Published Prlog - 21 hours ago]
BRIEF-Cosmo Pharmaceuticals says Ferring's CORT... [Published Reuters - Oct 20 2014]
TxCell to present on T cellular therapy for aut... [Published PharmaBiz - Oct 20 2014]
St. Louis Public Library: 150 Years in the Making [Published Ladue News - Oct 17 2014]
September and October SMC decisions [Published Pharmaceutical Journal - Oct 16 2014]
TxCell to provide overview of T cellular therap... [Published News-Medical.Net - Oct 16 2014]
TxCell to present on T Cellular Therapy for Aut... [Published Scottrade - Oct 16 2014]
Key Cosmo shareholders announce that they suppo... [Published 4 Traders - Oct 16 2014]
Cosmo Pharmaceuticals : Key Cosmo shareholders ... [Published 4 Traders - Oct 16 2014]
Is a Statutory Patent Disclaimer Sufficient Eno... [Published FDA Law Blog - Oct 15 2014]
FDA grants a combo-med exclusivity wish. Why is... [Published FiercePharma - Oct 15 2014]
Ferring B.V. v. Watson Labs., Inc.—Florida (I) [Published JD Supra - Oct 15 2014]
Novartis MS pill heads stream of SMC approvals [Published Pharma Times - Oct 13 2014]
36.) LogiXML Offers Business Intelligence for t... [Published Software Magazine - Oct 13 2014]
WHISPERING SMITH: Battery hens recharged by cha... [Published Littlehampton Gazette - Oct 11 2014]
Determining infringement by reference to ANDA s... [Published Inside Counsel - Oct 10 2014]
Standard Heightened for Injunction in Trademark... [Published JD Supra - Oct 09 2014]
The impact of eBay on Lanham Act false advertis... [Published Lexology - Oct 09 2014]
Ferring Pharma to launch new cranberry flavour ... [Published PharmaBiz - Oct 09 2014]
Silence of ANDA with Respect to a Claim Limitat... [Published JD Supra - Oct 08 2014]
Yamaha Pianos to Play Key Role in Newly Expande... [Published PRWeb - Oct 08 2014]
Uceris® patent protection extended from 2020 un... [Published 4 Traders - Oct 08 2014]
Ferring Pharmaceuticals to introduce new cranbe... [Published BioPortfolio - Oct 07 2014]
Ferring Pharmaceuticals to introduce new cranbe... [Published News-Medical.Net - Oct 07 2014]
Managing growth at multinationals: Acquisitions... [Published WorldCity - Oct 07 2014]
Jazz St. Louis Opens to the World [Published Stock Nod - Oct 03 2014]
Jazz St. Louis Opens to the World [Published Minyanville - Oct 03 2014]
How we did it: Taking control using local conse... [Published Planning Resource - Oct 03 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Is a Statutory Patent Disclaimer Sufficient Eno... [Published FDA Law Blog - Oct 15 2014]
By Kurt R. Karst –For several months now we have been monitoring an appeal to the U.S. Court of Appeals for the Federal Circuit concerning a patent – U.S. Patent No. 6,878,703 (“the ‘703 patent”) – listed in the Orange Book for Daiichi Sankyo Inc.’s (“Daiichi”) ...
[tt] Gowlett, Gamble, and Dunbar: Human Evoluti... [Published TranshumanTech - Sep 24 2014]
Gowlett, Gamble, and Dunbar: Human Evolution and the Archaeology of theSocial BrainCurrent AnthropologyVol. 53, No. 6, December 2012John Gowlett, Clive Gamble, and Robin DunbarJohn Gowlett is Professor at the School of Archaeology, Classics, andEgyptology, ...
Ferring B.V. v. Watson Laboratories, Inc. (II) ... [Published Patent Docs - Sep 02 2014]
By Kevin E. Noonan -- In the second of a pair of decisions issued last Friday, styled Ferring B.V. v. Watson Laboratories, Inc., the Federal Circuit affirmed a finding by the District Court that the generic ANDA challenger had not shown the asserted claims ...
Ferring B.V. v. Watson Laboratories, Inc. (I) (... [Published Patent Docs - Aug 29 2014]
By Kevin E. Noonan -- In the first of a pair of decisions issued last Friday, Ferring B.V. v. Watson Laboratories, Inc., the Federal Circuit affirmed a finding by the District Court that a generic company could moot ANDA litigation by amending its application ...
Ferring Pharmaceuticals and Roche collaborate t... [Published EON Consumer - Jun 24 2014]
SAINT-PREX & ROTKREUZ, Switzerland--(EON: Enhanced Online News)--Ferring’s follicle-stimulating hormone is in development with a companion diagnostic test from Roche to help improve the clinical management of infertility treatment ...
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.